Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

Harmony Biosciences Holdings, Inc. (HRMY) had Revenue of $184.73M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$184.73M
Net Income	$45.56M
Cost of Goods Sold	$31.99M
Gross Profit	$152.74M
Operating Expenses	$128.49M
Operating Income	$56.24M
Non-Operating Income/Expense	$0.93M
Pre-Tax Income	$57.18M
Normalized Pre-Tax Income	$57.18M
Income after Taxes	$45.56M
Income from Continuous Operations	$45.56M
Consolidated Net Income/Loss	$45.56M
Normalized Income after Taxes	$45.56M
EBIT	$56.24M
EBITDA	$61.93M
Weighted-Average Shares Outstanding (Basic)	57.31M
Weighted-Average Shares Outstanding (Diluted)	58.52M
Earnings per Share (EPS) (Basic)	$0.79
Earnings per Share (EPS) (Diluted)	$0.78
Balance Sheet Financials
Current Assets	$642.69M
Property, Plant, and Equipment	$1.38M
Long-Term Assets	$412.84M
Total Assets	$1.06B
Current Liabilities	$175.12M
Long-Term Debt	$158.18M
Long-Term Liabilities	$159.89M
Total Liabilities	$335.01M
Common Equity	$720.52M
Tangible Shareholders Equity	$613.22M
Shareholders Equity	$720.52M
Common Shares Outstanding	57.39M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$33.99M
Cash Flow from Investing Activities	$2.36M
Cash Flow from Financial Activities	$-0.35M
Beginning Cash	$453.27M
End Cash	$489.27M
Increase/Decrease in Cash	$36.00M
Stock-Based Compensation	$12.50M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.67
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.18
Debt to Equity Ratio	0.24
Gross Margin	82.68%
Operating Margin	30.45%
EBIT Margin	30.45%
EBITDA Margin	--
Pre-Tax Profit Margin	30.95%
Profit Margin	24.66%
Free Cash Flow	$33.86M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.17
Inventory Turnover	5.01
Receiveable Turnover	1.74
Days Sales in Receivables	51.63
Return on Equity	6.32%
Return on Tangible Equity	7.43%
Return on Assets	4.32%
Return on Investments	5.18%
Book Value Per Share	$12.55
Free Cash Flow per Share	$0.58
Operating Cash Flow per Share	$0.58

Data from Zacks Investment Research, Inc.